The GREAT trial
Gait Rehabilitation in Early Arthritis Trial
Multicentre randomised controlled trial (RCT) design where patients are individually randomised on a 1:1 allocation ratio to receive either usual care or usual care plus intervention.
The intervention is treatment sessions over 12 weeks to guide participants for undertaking a gait rehabilitation programme comprised of functional walking tasks and will include a supported home-based gait rehabilitation programme and an embedded psychological component to promote positive sustainable change.
Prof Martijn Steultjens (Glasgow Caledonian University)
Gordon Hendry (Glasgow Caledonian University)
Local PI – Dr Samantha Hider
Central – Lisa JollyLocal – Sarah Bathers
|Sponsor / Reference Number:||Keele University|
|Funder / Reference Number:||National Institute for Health Research – Health Technology Assessment Programme / 15/165/04|
|UKCRN Study Portfolio Reference Number:||38124|
|Registration Reference Number:||ISRCTN18132064|
|Start Date:||31 Oct 2017|
|End Date:||Oct 2024|
Aim and objectives
Does the addition of a specifically designed gait rehabilitation programme to standard care improve lower limb function in early rheumatoid arthritis patients?
Objectives for main trial phase:
- To compare the clinical effectiveness of the addition of a new gait rehabilitation intervention to usual care versus usual care alone on lower limb function
- To compare the cost-effectiveness of the addition of a new gait rehabilitation intervention to usual care versus usual care alone
- To evaluate participants’ view and experiences of the usual care and gait rehabilitation interventions.
- To evaluate intervention therapists’ (physiotherapists and podiatrists) view and experiences of the usual care and gait rehabilitation interventions and trial processes.